A panel of consultants has concluded {that a} widespread ingredient in over-the-counter decongestants doesn’t work. This might result in the product being pulled from retailer cabinets.
AILSA CHANG, HOST:
And now some information for anybody on the market who has ever wandered down the medication aisle on the lookout for one thing to clear up their stuffy nostril. Seems a key ingredient in lots of fashionable over-the-counter decongestants doesn’t work. That was the conclusion of a panel of consultants who suggested the Meals and Drug Administration who met yesterday. NPR’s Will Stone joins us now to clarify what’s going on. Hey, Will.
WILL STONE, BYLINE: Hello, Ailsa.
CHANG: OK, so set the stage for us right here. What precisely is that this drug?
STONE: Yeah, it’s kind of of a mouthful. It is referred to as phenylephrine, and you may see it abbreviated as PE on packaging. It is discovered in lots of fashionable chilly and allergy decongestants which might be taken by mouth and offered over-the-counter. And mainly, these FDA advisers reviewed all of the proof, particularly the newer research, they usually concluded that it is not efficient, not less than when taken orally. They usually had been so satisfied, it was truly a unanimous suggestion.
CHANG: Unanimous. OK, so what does this virtually imply for these medication?
STONE: Properly, the FDA doesn’t need to observe the suggestions of its advisers. Given the power of the proof, the expectation of many consultants, together with Randy Hatton who’s on the College of Florida, is that they’ll agree with the evaluation that it is ineffective.
RANDY HATTON: Which might ultimately result in these merchandise being faraway from the market. Now, there are a lot of merchandise that may comprise this. I imply, it could clearly change the looks of the cough and chilly and allergy aisles at your native pharmacy.
CHANG: Unbelievable.
STONE: And Hatton is definitely very near this battle over phenylephrine. He began trying into whether or not this labored round 20 years in the past and was one of many researchers who requested the FDA to look into it. And the science right here is mainly that once you take phenylephrine orally at this dose, the drug will get damaged down and would not find yourself truly serving to your nostril.
CHANG: (Laughter).
STONE: Regardless of this, although, these merchandise had been liable for virtually $2 billion in gross sales simply final 12 months alone.
CHANG: I imply, that’s outstanding, Will. How did this ineffective drug ever find yourself on cabinets within the first place?
STONE: Yeah. It seems that phenylephrine has been round for a very long time, and whereas we all know it is protected, it basically acquired grandfathered in and went by way of a unique course of than what’s required for newer medication that come in the marketplace. Hatton says it was type of an accident of historical past as a result of within the early 2000s, laws was handed to fight methamphetamine use, and that led to pseudoephedrine, which was broadly used on the time, transferring behind the pharmacy counter. Pseudoephedrine can be utilized to make meth. So on account of all of this, phenylephrine changed it in lots of of those fashionable decongestants which might be offered over-the-counter.
Stefanie Ferreri is on the UNC Eshelman Faculty of Pharmacy. She remembers what she was listening to when these merchandise first turned fashionable.
STEFANIE FERRERI: When it first got here out, lots of people had been like, this does not appear to be working as properly. This does not appear to be working as properly. In order a pharmacist, we heard a whole lot of anecdotal proof from our sufferers saying it was not as efficient because the pseudoephedrine, which was additionally in the marketplace.
STONE: Ferreri says she hopes that this reckoning over phenylephrine prompts the FDA to have a look at the proof base for different older over-the-counter medication. Among the concern round phenylephrine is that whereas it is not harmful, sufferers have been taking it, and if it is not working, it is basically resulting in delays in care and never truly resolving their signs.
CHANG: Precisely. OK, so what are the implications right here as all of us roll into a brand new chilly season?
STONE: Yeah, properly, there are definitely different choices for individuals who want a decongestant. There’s pseudoephedrine, which Ferreri simply talked about. It is offered behind the counter. You have to present your ID, however you do not want a prescription for it. I spoke to Dr. Derrick Ward, who’s with Kansas Metropolis Allergy & Bronchial asthma Associates. He says he cannot actually bear in mind a time in his 17 years of observe when he is really useful phenylephrine.
DERRICK WARD: If I’ll suggest a decongestant to someone, I’d sometimes both suggest a brief course of a nasal decongestant spray, , like a generic Afrin, often for 3 to five days. Possibly if they have a chilly or one thing like that or sinus an infection or an oral – if I’ll do an oral decongestant, I’d virtually at all times suggest we use pseudoephedrine.
STONE: So backside line, Ailsa, whereas this information about phenylephrine might create some confusion amongst shoppers, it might upset the market – if it does get pulled, medical doctors and pharmacists say there are nonetheless loads of good choices for shoppers.
CHANG: That’s NPR’s Will Stone. Thanks a lot, Will.
STONE: Thanks.
Copyright © 2023 NPR. All rights reserved. Go to our web site phrases of use and permissions pages at www.npr.org for additional data.
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content will not be in its closing kind and could also be up to date or revised sooner or later. Accuracy and availability might fluctuate. The authoritative report of NPR’s programming is the audio report.
